146 results on '"Weaver, James L."'
Search Results
2. Development and validation of a liquid-chromatography tandem mass spectrometry method to determine in vitro and in vivo histamine release
3. Review
4. Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development – (III) A Randomized Trial with Interferon Beta‐1a Products.
5. Evaluating the Utility of Proteomics for the Identification of Circulating Pharmacodynamic Biomarkers of IFNβ‐1a Biologics.
6. Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development – (II) A Randomized Trial with IL‐5 Antagonists.
7. Evaluation of a Sequential Antibiotic Treatment Regimen of Ampicillin, Ciprofloxacin and Fosfomycin against Escherichia coli CFT073 in the Hollow Fiber Infection Model Compared with Simultaneous Combination Treatment.
8. Calibration and Validation of a Mechanistic COVID‐19 Model for Translational Quantitative Systems Pharmacology – A Proof‐of‐Concept Model Development for Remdesivir.
9. Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part I. Biotherapeutics
10. Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part 2. Antisense Oligonucleotides
11. Nonclinical evaluation of the potential for mast cell activation by an erythropoietin analog
12. Expanding Approved Patient Populations for Rare Disease Treatment Using In Vitro Data.
13. The Role of eNOS Phosphorylation in Causing Drug-induced Vascular Injury
14. Nonclinical Safety Biomarkers of Drug-induced Vascular Injury: Current Status and Blueprint for the Future
15. Effects of sedative psychotropic drugs combined with oxycodone on respiratory depression in the rat.
16. Establishing the Carcinogenic Risk of Immunomodulatory Drugs
17. Effects of Modulating In Vivo Nitric Oxide Production on the Incidence and Severity of PDE4 Inhibitor–Induced Vascular Injury in Sprague-Dawley Rats
18. Early Events in Vascular Injury in the Rat Induced by the Phosphodiesterase IV Inhibitor SCH 351591
19. Anti–SARS‐CoV‐2 Repurposing Drug Database: Clinical Pharmacology Considerations.
20. Considerations in Assessing the Immunotoxic Potential of Investigational Drugs
21. Histopathology of Vascular Injury in Sprague-Dawley Rats Treated with Phosphodiesterase IV Inhibitor SCH 351591 or SCH 534385
22. Biomarkers in Peripheral Blood Associated with Vascular Injury in Sprague-Dawley Rats Treated with the Phosphodiesterase IV Inhibitors SCH 351591 or SCH 534385
23. Evaluation of the Tg.AC Assay: Specificity Testing with Three Noncarcinogenic Pharmaceuticals that Induce Selected Stress Gene Promoters in Vitro and the Inhibitory Effects of Solvent Components
24. BLT-Immune Humanized Mice as a Model for Nivolumab-Induced Immune-Mediated Adverse Events: Comparison of the NOG and NOG-EXL Strains.
25. Advancing Biosimilar Development Using Pharmacodynamic Biomarkers in Clinical Pharmacology Studies.
26. Investigating the susceptibility of mice to a bacterial challenge after intravenous exposure to durable nanoparticles.
27. Evaluating the potential of gold, silver, and silica nanoparticles to saturate mononuclear phagocytic system tissues under repeat dosing conditions.
28. Closing the gap: accelerating the translational process in nanomedicine by proposing standardized characterization techniques.
29. Using the Media Classes.
30. BackMatter.
31. JavaFX Languages and Markup.
32. Collections and Concurrency.
33. Accessing Web Services.
34. Using the JavaFX UI Controls.
35. Getting a Jump Start in JavaFX.
36. Creating Charts in JavaFX.
37. Creating a User Interface in JavaFX.
38. Building Dynamic UI Layouts in JavaFX.
39. Properties and Bindings.
40. FrontMatter.
41. Biomedical Uses of Flow Cytometry.
42. Flow Cytometry in the Biomedical Arena.
43. X-ray spectroscopy and calibrations in the 50- to 60-keV range.
44. Characterization of silicon photodiode detectors with multilayer filter coatings for 17 to 150 A.
45. Estimation of Drug Resistance by Flow Cytometry.
46. Estimation of Cell Viability by Flow Cytometry.
47. Evaluation of nanoparticle immunotoxicity.
48. High-resolution imaging spectrometer for recording absolutely calibrated far ultraviolet spectra from laser-produced plasmas.
49. Histopathology of Vascular Injury in Sprague-Dawley Rats Treated with Phosphodiesterase IV Inhibitor SCH 351591 or SCH 534385.
50. Development of a Phospholipidosis Database and Predictive Quantitative Structure-Activity Relationship (QSAR) Models.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.